Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiplatelet treatment for prevention of vascular outcomes in peripheral artery disease patients undergoing peripheral revascularization
2012-000997-53Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Aug 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of aspirin and clopidogrel in arteriosclerosis obliterans, sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Primary endpoint: Target vessel thrombosis absence. Started Aug 2012; status: active.
02
Drugs
aspirinclopidogrel
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on 2012-000997-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000997-53.